IRIS
BRUNETTI, Lorenzo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.609
EU - Europa 1.500
AS - Asia 1.129
SA - Sud America 198
Continente sconosciuto - Info sul continente non disponibili 130
AF - Africa 49
OC - Oceania 2
Totale 5.617
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.491
RU - Federazione Russa 787
SG - Singapore 371
IT - Italia 236
VN - Vietnam 223
CN - Cina 171
HK - Hong Kong 158
BR - Brasile 150
IE - Irlanda 105
FR - Francia 79
SE - Svezia 78
GB - Regno Unito 70
IN - India 55
CA - Canada 49
DE - Germania 41
BD - Bangladesh 29
LT - Lituania 24
FI - Finlandia 22
ID - Indonesia 20
ZA - Sudafrica 19
AR - Argentina 17
NL - Olanda 16
SV - El Salvador 12
TR - Turchia 12
PH - Filippine 11
AT - Austria 10
CI - Costa d'Avorio 10
GT - Guatemala 10
JP - Giappone 10
PK - Pakistan 10
MX - Messico 9
BE - Belgio 8
IQ - Iraq 7
JM - Giamaica 7
KR - Corea 7
MA - Marocco 7
PL - Polonia 7
TH - Thailandia 7
CO - Colombia 6
NI - Nicaragua 6
VE - Venezuela 6
CL - Cile 5
CR - Costa Rica 5
EC - Ecuador 5
ES - Italia 5
MY - Malesia 5
PS - Palestinian Territory 5
TT - Trinidad e Tobago 5
DZ - Algeria 4
KE - Kenya 4
PY - Paraguay 4
CW - ???statistics.table.value.countryCode.CW??? 3
DO - Repubblica Dominicana 3
GP - Guadalupe 3
HN - Honduras 3
JO - Giordania 3
LB - Libano 3
PA - Panama 3
UA - Ucraina 3
AU - Australia 2
AZ - Azerbaigian 2
BH - Bahrain 2
EG - Egitto 2
GR - Grecia 2
IL - Israele 2
KG - Kirghizistan 2
KZ - Kazakistan 2
NP - Nepal 2
OM - Oman 2
PR - Porto Rico 2
RO - Romania 2
RS - Serbia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AM - Armenia 1
BG - Bulgaria 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
GE - Georgia 1
GY - Guiana 1
LA - Repubblica Popolare Democratica del Laos 1
LS - Lesotho 1
ML - Mali 1
MT - Malta 1
PE - Perù 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 5.490
Salva come PNG Salva come JPEG
Città #
Ashburn 525
Chandler 338
Singapore 221
San Jose 175
Hong Kong 152
Council Bluffs 119
Dublin 99
Dallas 98
Boardman 81
The Dalles 80
Ho Chi Minh City 62
Fairfield 48
Hanoi 48
Lauterbourg 46
Los Angeles 43
Ancona 40
Beijing 37
Lawrence 35
Moscow 35
Princeton 35
Boston 33
Pune 33
Wilmington 31
Destin 29
Milan 27
Cambridge 26
New York 26
London 23
Santa Clara 23
Helsinki 21
São Paulo 21
Vilnius 21
Buffalo 18
Houston 17
Phoenix 17
Des Moines 16
Bologna 15
Montesilvano Marina 15
Nuremberg 15
Shanghai 14
Chicago 13
Rome 13
Brooklyn 12
Columbus 12
Frankfurt am Main 12
Jakarta 12
Washington 12
Hefei 11
Johannesburg 11
Montreal 11
Seattle 11
Abidjan 10
Atlanta 10
Guatemala City 10
Haiphong 10
San Diego 10
San Francisco 10
Tokyo 10
Toronto 10
Woodbridge 10
Brussels 8
Da Nang 8
Haikou 8
Salt Lake City 8
San Salvador 8
Denver 7
Guangzhou 7
Miano 7
Milwaukee 7
Amsterdam 6
Hải Dương 6
Managua 6
Manchester 6
San Vitaliano 6
Warsaw 6
Bangkok 5
Can Tho 5
Orem 5
Porto Alegre 5
Rio de Janeiro 5
Roubaix 5
Ankara 4
Ann Arbor 4
Biên Hòa 4
Elk Grove Village 4
Jiaxing 4
Kuala Selangor 4
Lynnwood 4
Mexico City 4
Miami 4
Newark 4
Poplar 4
Seoul 4
Thái Nguyên 4
Verona 4
Vienna 4
Acton 3
Amman 3
Belém 3
Brampton 3
Totale 3.184
Salva come PNG Salva come JPEG
Nome #
Highly efficient gene disruption of murine and human hematopoietic progenitor cells by CRISPR/Cas9 699
Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells 175
Mutant NPM1 directly regulates oncogenic transcription in acute myeloid leukemia 160
NPM1-mutated acute myeloid leukemia: From bench to bedside 154
DNMT3A-coordinated splicing governs the stem state switch towards differentiation in embryonic and haematopoietic stem cells 136
How I diagnose and treat NPM1-mutated AML 129
Mutant NPM1 Maintains the Leukemic State through HOX Expression 128
CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression 128
Breast Cancer With Release of Tumor Cells in Peripheral Blood Mimicking Acute Myeloid Leukemia 127
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML 122
Current status and future perspectives in targeted therapy of NPM1-mutated AML 118
Actinomycin d targets npm1c-primed mitochondria to restore pml-driven senescence in aml therapy 116
Aerobic Plus Resistance Exercise in Obese Older Adults Improves Muscle Protein Synthesis and Preserves Myocellular Quality Despite Weight Loss 114
CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice 112
DNMT3A in Leukemia 108
Perspectives for therapeutic targeting of gene mutations in acute myeloid leukaemia with normal cytogenetics 107
Diagnostic and therapeutic pitfalls in NPM1-mutated AML: notes from the field 102
NOVEL NPM1 EXON 5 MUTATIONS AND GENE FUSIONS LEADING TO ABERRANT CYTOPLASMIC NUCLEOPHOSMIN IN AML 102
Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice 100
CD123 is consistently expressed on NPM1-mutated AML cells 96
Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9 94
Perturbed hematopoiesis in individuals with germline DNMT3A overgrowth Tatton-Brown-Rahman syndrome 93
Effect of the COVID-19 pandemic on laboratory and clinical research: A testimony and a call to action from researchers 89
An atypical GABARAP binding module drives the pro-autophagic potential of the AML-associated NPM1c variant 88
CD200/OX2, a cell surface molecule with immuno-regulatory function, is consistently expressed on hairy cell leukaemia neoplastic cells: Correspondence 88
Nutrient-sensitive transcription factors TFEB and TFE3 couple autophagy and metabolism to the peripheral clock 88
Large-scale GMP-compliant CRISPR-Cas9-mediated deletion of the glucocorticoid receptor in multivirus-specific T cells 86
TFEB regulates murine liver cell fate during development and regeneration 84
Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells 80
AML-099 Prolonged XPO1 Inhibition Is Essential for Optimal Anti-Leukemic Activity in NPM1-Mutated AML 79
Prenatal diagnosis of familial hemophagocytic lymphohistiocytosis: morphological findings in the product of conception 79
Modeling IKZF1 lesions in B-ALL reveals distinct chemosensitivity patterns and potential therapeutic vulnerabilities 79
Tissue-Biased Expansion of DNMT3A-Mutant Clones in a Mosaic Individual Is Associated with Conserved Epigenetic Erosion 78
Blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia: A shared clonal origin 78
Systematic profiling of DNMT3A variants reveals protein instability mediated by the DCAF8 E3 ubiquitin ligase adaptor 78
Response to: “Cytoplasmic dislocation of NPM1 and PU.1 in NPM1-mutated leukemia is obscured by paraformaldehyde fixation” 77
It's All About MEis: Menin-MLL Inhibition Eradicates NPM1-Mutated and MLL-Rearranged Acute Leukemias in Mice 76
Dactinomycin in NPM1-Mutated acute myeloid leukemia 74
Mutant NPM1 marginally impacts ribosome footprint in acute myeloid leukemia cells 73
Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML 72
Loss of Capicua alters early T cell development and predisposes mice to T cell lymphoblastic leukemia/lymphoma 72
Overlapping features of therapy-related and de novoNPM1-mutated AML 71
DNA epigenome editing using CRISPR-Cas SunTag-directed DNMT3A 71
Mutant NPM1: Nuclear export and the mechanism of leukemogenesis 70
New insights into the biology of acute myeloid leukemia with mutated NPM1 69
PU.1 subcellular localization in acute myeloid leukaemia with mutated NPM1 67
The absent/low expression of CD34 in NPM1-mutated AML is not related to cytoplasmic dislocation of NPM1 mutant protein 65
A venetoclax and azacitidine bridge-to-transplant strategy for NPM1-mutated acute myeloid leukaemia in molecular failure 62
NPM1-mutated AML with starry sky pattern 62
The NPM1 mutant defines AML irrespective of blast count 51
Prolonged XPO1 inhibition is essential for optimal anti-leukemic activity in NPM1-mutated AML 50
Impact of Pre-Treatment Comorbidity Burden on Survival in Patients Receiving Venetoclax Plus Hypomethylating Agents 49
Real-world multicenter analysis of CPX-351 efficacy in patients aged less than 60 years with secondary acute myeloid leukemia 47
Real World Study on the Best CPX-351 Treatment Duration and Timing for Allogeneic Stem Cell Transplantation 38
Disparate leukemia mutations converge on nuclear phase-separated condensates 31
Nuclear Transcriptional Condensates as Drivers and Therapeutic Targets in NPM1-mutated AML 21
Correction: Real-world multicenter analysis of CPX-351 efficacy in patients aged less than 60 years with secondary acute myeloid leukemia(Blood Cancer Journal, 10.1038/s41408-025-01394-7) 19
NPM1 and IDH1/2 Mutations Show Limited Prognostic Impact in Relapsed/Refractory AML: Evidence From the AVALON Cohort 19
Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351 17
Totale 5.617
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.043
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.043
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022270 0 0 0 0 53 48 1 11 49 8 22 78
2022/2023689 67 80 49 77 49 64 6 57 171 2 29 38
2023/2024969 80 15 37 50 48 205 130 132 77 98 56 41
2024/2025790 77 75 13 18 19 45 72 59 175 44 92 101
2025/20262.252 93 108 157 78 209 195 474 220 265 229 102 122
2026/2027626 80 85 101 350 10 0 0 0 0 0 0 0
Totale 5.617